Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
157.00
-8.78 (-5.30%)
At close: Oct 30, 2026, 4:00 PM EDT
160.75
+3.75 (2.39%)
After-hours: Oct 30, 2026, 7:57 PM EDT
Revvity Revenue
Revvity had revenue of $729.69M in the quarter ending July 5, 2026, with 1.31% growth. This brings the company's total for the last twelve months to $2.91B, up 4.05% year-over-year. In the year 2025, Revvity had annual revenue of $2.86B with 3.67% growth. That makes Revvity the 3,901st largest company in the world by revenue and 1,072nd in the United States.
Revenue (ttm)
$2.91B
Revenue Growth
+4.05%
P/S Ratio
6.02
Revenue / Employee
$264,710
Employees
11,000
Market Cap
17.52B
Revenue by Segment
Fiscal year ended Dec 28, 2025 See the full Revvity breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.86B | 101.03M | 3.67% |
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
| Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
| Dec 30, 2018 | 2.78B | 521.01M | 23.08% |
| Dec 31, 2017 | 2.26B | 141.47M | 6.69% |
| Jan 1, 2017 | 2.12B | 10.69M | 0.51% |
| Jan 3, 2016 | 2.10B | 34.94M | 1.69% |
| Dec 28, 2014 | 2.07B | -87.71M | -4.07% |
| Dec 29, 2013 | 2.16B | 52.40M | 2.49% |
| Dec 30, 2012 | 2.11B | 186.68M | 9.73% |
| Jan 1, 2012 | 1.92B | 216.74M | 12.74% |
| Jan 2, 2011 | 1.70B | 151.00M | 9.74% |
| Jan 3, 2010 | 1.55B | -108.90M | -6.56% |
| Dec 28, 2008 | 1.66B | -69.21M | -4.00% |
| Dec 30, 2007 | 1.73B | 251.19M | 17.00% |
| Dec 31, 2006 | 1.48B | 3.85M | 0.26% |
| Jan 1, 2006 | 1.47B | 44.74M | 3.13% |
| Jan 2, 2005 | 1.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 17.31B |
| Labcorp Holdings | 14.59B |
| Quest Diagnostics | 11.84B |
| ICON Public Limited Company | 8.23B |
| IDEXX Laboratories | 4.55B |
| Illumina | 4.49B |
| Mettler-Toledo International | 4.13B |
| Charles River Laboratories International | 4.00B |
RVTY News
- 1 day ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 11 days ago - Citrini bullish on Charles River, Revvity after testing Claude, Bloomberg says - TheFly
- 11 days ago - Revvity announces Revvity Signals Software launch of Signals LabGistics - TheFly
- 11 days ago - Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows - Business Wire
- 17 days ago - How to Invest in AI Drug Discovery - ETF Trends
- 18 days ago - Revvity price target raised to $175 from $130 at TD Cowen - TheFly
- 18 days ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 22 days ago - Revvity price target raised to $165 from $125 at BofA - TheFly